Sujets)
Glycémie/effets des médicaments et des substances chimiques , Carbamates/administration et posologie , Diabète de type 2/traitement médicamenteux , Relation dose-effet des médicaments , Calendrier d'administration des médicaments , Humains , Hyperglycémie/traitement médicamenteux , Hypoglycémiants/administration et posologie , Pipéridines/administration et posologie , Période post-prandiale , Sensibilité et spécificitéRésumé
A total of 768 patients were recruited by 81 physicians and paediatricians all over the country in this National Study Group of 'Ascoril + Expectorant'. The results of this first large scale study of a cough formula indicates that 'Ascoril + Expectorant' is effective in controlling cough, breathlessness and decreasing the volume of sputum. No serious adverse events were noted. Ascoril was well accepted by the patients and its efficacy was rated very high by the physician. The National Study Group concludes that 'Ascoril + Expectorant' is highly effective in the management of cough associated with lower respiratory tract infection and COPDs.
Sujets)
Adolescent , Adulte , Sujet âgé , Bromhexine/effets indésirables , Enfant , Enfant d'âge préscolaire , Toux/traitement médicamenteux , Association médicamenteuse , Expectorants/effets indésirables , Femelle , Guaïfénésine/effets indésirables , Humains , Inde , Mâle , Menthol/effets indésirables , Adulte d'âge moyen , Terbutaline/effets indésirables , Résultat thérapeutiqueRésumé
Physicians (n = 84) across the country prescribed candid-B cream (clotrimazole 1% + beclomethasone dipropionate 0.025%) on 822 patients suffering from candidiasis with inflammatory diseases to evaluate the efficacy and safety of the combination. The results showed reduction in severity was more than 80% for all symptoms/signs except scaling and lichenification where the reduction was 76.05% and 66.03% respectively. Only one patient complained of adverse reaction. So in the treatment of coexisting candidiasis and inflammatory dermatoses the combination of clotrimazole 1% + beclomethasone 0.025% (candid-B cream) was found to be highly effective.